Pre-Market Surge Sustained For C4 Therapeutics (CCCC) Stock
Fahim Awan
December 13, 2023
C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are evidently sustaining the upward momentum initiated on Tuesday. Presently, C4 Therapeutics stock exhibits a 17.09% surge, reaching $2.74